Suchergebnisse - "Marreaud, Sandrine"

1

Reply to P. Potemski and K. Bujko

von: Schmoll, Hans-Joachim

2021, in: Journal of clinical oncology

Wird geladen...
2

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study

von: Verschoor, Arie Jan

2020, in: Clinical Sarcoma Research

Wird geladen...
3

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)

von: Fumoleau, Pierre

2014, in: The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study

Wird geladen...
4

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression

von: Wildiers, Hans

2022, in: The clinical outcomes of endovenous microwave and laser ablation for varicose veins: A prospective study

Wird geladen...
5

Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG▪

von: Brausi, Maurizio

2014, in: Phase transition and alternation in a model of perceptual bistability in the presence of Lévy noise

Wird geladen...
6

Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity

von: Vlenterie, Myrella

2016, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
7

Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

von: Frezza, Anna Maria

2014, in: Clinical Sarcoma Research

Wird geladen...
8

Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial

von: Hristova, Ivalina

2015, in: European journal of nuclear medicine and molecular imaging

Wird geladen...
9

First-line chemotherapy in advanced intra-abdominal well-differentiated/dedifferentiated liposarcoma : an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis

von: Stacchiotti, Silvia

13 May 2022, in: Cancer

Wird geladen...
10

Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)

von: Stadler, Rudolf

2021, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
11

The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial

von: Pasquali, Sandro

2019, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
12

Efficacy thresholds for clinical trials with advanced or metastatic leiomyosarcoma patients: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group meta-analysis based on a literature review for soft-tissue sarcomas

von: Kantidakis, Georgios

2021, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
13

The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with

von: Schöffski, Patrick

2018, in: European journal of cancer

Wird geladen...
14

Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

von: Kerklaan, Bojana Milojkovic

2012, in: Cancer chemotherapy and pharmacology

Wird geladen...
15

Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

von: Milojkovic Kerklaan, Bojana

2013, in: Cancer chemotherapy and pharmacology

Wird geladen...
16

New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas

von: Kantidakis, Georgios

2022, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
17

EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group

von: Wagner, Anna Dorothea

2019, in: BMC cancer

Wird geladen...
18

New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients : an EORTC - Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas

von: Kantidakis, Georgios

8 September 2022, in: European journal of cancer

Wird geladen...
19

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

von: Schöffski, Patrick

2017, in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study

Wird geladen...
20

Activity of eribulin mesylate in patients with soft-tissue sarcoma : a phase 2 study in four independent histological subtypes

von: Schöffski, Patrick

[October 2011], in: The lancet. Oncology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!